Further, 11.8% (49/414) of total participants haddetectable PSA levels between 1.5 and 2.49 ng/ml, and of these, 57.1% (28/49)had never discussed the pros and cons of PCa screening with a physician (Figure 1). Here, KLK3 is linked to posterior cortical atrophy.